Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status. ‌ Jarius, S, Paul, F, Franciotta, D, Aktas, O, Hohlfeld, R, Zipp, F, Vincent, A

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. ‌ Jarius, S, Paul, F, Franciotta, D, Waters, P, Zipp, F, Hohlfeld, R, Vincent, A, Wildemann, B

Characterizing microstructural tissue properties in Multiple Sclerosis with diffusion MRI at 7 T and 3 T: The impact of the experimental design ‌ De Santis, S, Bastiani, M, Droby, A, Kolber, P, Zipp, F, Pracht, E, Stoecker, T, Groppa, S, Roebroeck, A

Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis ‌ Jarius, S, Paul, F, da Silva, A, Leite, M, Waters, P, Littleton, E, Franciotta, D, Palace, J, Zipp, F, Vincent, A

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. ‌ Paul, F, Jarius, S, Aktas, O, Bluthner, M, Bauer, O, Appelhans, H, Franciotta, D, Bergamaschi, R, Littleton, E, Palace, J, Seelig, H, Hohlfeld, R, Vincent, A, Zipp, F

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. ‌ Sawcer, S, Hellenthal, G, Pirinen, M, Spencer, C, Patsopoulos, N, Moutsianas, L, Dilthey, A, Su, Z, Freeman, C, Hunt, SE, Edkins, S, Gray, E, Booth, DR, Potter, S, Goris, A, Band, G, Oturai, AB, Strange, A, Saarela, J, Bellenguez, C, Fontaine, B, Gillman, M, Hemmer, B, Gwilliam, R, Zipp, F

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. ‌ Beecham, A, Patsopoulos, N, Xifara, D, Davis, M, Kemppinen, A, Cotsapas, C, Shah, T, Spencer, C, Booth, D, Goris, A, Oturai, A, Saarela, J, Fontaine, B, Hemmer, B, Martin, C, Zipp, F, D'Alfonso, S, Martinelli-Boneschi, F, Taylor, B, Harbo, H, Kockum, I, Hillert, J, Olsson, T, Ban, M, Oksenberg, JR